Jennifer Jin
Partner @ Advantech Capital
Central, Hong Kong
Jennifer Jin is a Series B investor at Advantech Capital in Central focused on Medical and Health Care. Jennifer Jin is the Partner of Advantech Capital.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Jennifer Jin invests in
Stages Jennifer Jin invests in
Countries Jennifer Jin invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Clinical Trials 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Connect Biopharmaceuticals
|
Connect Biopharmaceuticals is a clinical-stage company that discovers and develops novel medicines for the treatment of autoimmune diseases and inflammation. They identify and advance our drug candidates through in-house discovery and in-licensing while leveraging qualified CROs for further development. The company successfully completed a phase Iclinical trial study on our leading program CBP-307, a novel and selective second-generation S1P1 (a G-protein coupled receptor -GPCR) modulator for the treatment of a range of autoimmune disorders, including multiple sclerosis, inflammatory bowel disease, and psoriasis.Connect Biopharmaceuticals currently conducting two phases 2 clinical studies in patients with ulcerative colitis and Crohn's disease with their lead drug candidate CBP-307. It also concluding a phase 1 study of our second drug candidate CBP-201 in healthy subjects, with a phase 1b study in atopic dermatitis patients expected to commence in Q1, 2019. Connect Biopharmaceuticals was founded in 2012 and is headquartered in Taichang, China. | $55M / Series B / Jan 03, 2019 |
Co-Investors
About Advantech Capital
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
Advantech Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hebert Kee Chan Pang
Director
|
|||
|
Jennifer Jin
Partner
|
|||
Benjamin Qiu
Partner
|
|||
Jianming Yu
Founder, Managing Partner
|
|||
Jianming Yu
Founder, Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jennifer Jin invest in?
Jennifer Jin invests primarily in Medical, Health Care and Therapeutics startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Jennifer Jin?
Public channels for Jennifer Jin include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Jennifer Jin last invest?
The most recent investment recorded for Jennifer Jin closed in Jan 2019. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
